FDA and other authorities have been trying to deal with the rapid adoption of social media but they have
not been able to publish the required guidance about how pharma can engage with social media.
AtWebicina.com, we decided to launch a project with a mission of creating a set of open access socialmedia guidelines for and about the pharma industry with the help of an expert crowd.This is "the key principles in a manifesto type document" which can be the overview for pharma tofollow. The guidance outlines the key principles such as protecting patients, keeping healthcare professionals informed, being transparent, reporting the Adverse Events, or following applicable codesand regulations in social media.
After months of hard collaborative work, we now publish „A Physician’s Rules of Engagement”; a„Pharma’s
Rules of Engagement”; Key Principles about how
pharma should use social media andtechnology specific guides as well.We hope this guide will initiate an even more extended collaboration and we, healthcare professionals,e-patients and pharma, can facilitate the process for the FDA of publishing its own guide.Show your support or feedback your thoughts on Twitter using#pharmaSMguide.
Join this project and see more details including positive and negative pharma-related social media case
studies onWebicina!Best regards,Dr. Bertalan MeskoManaging director of Webicina.com&Dr. Felix JacksonChief Medical Officer of medDigital
Open access social media guidelines for pharma